title: FDA must publish data on safety and efficacy of prophylactic AIDS drug, court rules.
authors: Nigel
authors: N
authors: Hawkes
mesh_terms: D022126:Access to Information / Q000331:legislation & jurisprudence; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D000068679:Emtricitabine; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D006801:Humans; D063065:Organophosphonates / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011643:Publishing / Q000331:legislation & jurisprudence; D000068698:Tenofovir; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine